Hypertension guidelines for CKD patients make practicing physicians confused
In a new CKJ review article, authors discuss the similarities and differences between three major guidelines that deal with hypertension and CKD and call for unified basic concepts to prevent confusion among patients and physicians.
Three major guidelines deal with blood pressure thresholds and targets for hypertensive drug therapy in CKD patients: the 2012 Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline; the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline and the 2018 European Society of Cardiology (ESC)/European Society of Hypertension (ESH) Guidelines. However, reading the three guidelines leaves the practicing physician confused about the definition of CKD, how hypertension and secondary hypertension should be diagnosed in CKD patients and what the BP thresholds and targets for antihypertensive drug therapy should be for this population. In a new CKJ review article, authors discussthe similarities and differences between these guidelines and call for unified basic concepts to prevent confusion among patients and physicians.
Find the paper in the CKJ here
